Covid-19 man­u­fac­tur­ing roundup: Biden dou­bles down on vac­ci­na­tion plan with 100M-dose or­der; BioN­Tech, Pfiz­er ready to in­crease man­u­fac­tur­ing; J&J ex­pe­ri­ences de­liv­ery woes

With head­lines around the globe fo­cused on var­i­ous hitch­es in the glob­al sup­ply chain for Covid vac­cines, Pres­i­dent Joe Biden is tak­ing out an in­sur­ance pol­i­cy of sorts to help guar­an­tee his promise to rapid­ly ex­pand ac­cess.

Ear­li­er in the week the pres­i­dent an­nounced plans for a new con­tract with J&J cov­er­ing an added 100 mil­lion dos­es of their one-shot jab to guard against Covid-19, to be de­liv­ered in the sec­ond half of the year. And much of that work will be done at Mer­ck’sDurham, NC fa­cil­i­ty, which re­cent­ly an­nounced plans to ex­pand its work­force by 100 at the 900,000-square-foot plant.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER